| Bioactivity | (+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (OVGP1)[1]. | ||||||||||||
| Target | PTGER2 | ||||||||||||
| Name | (+)-Fluprostenol | ||||||||||||
| CAS | 54276-17-4 | ||||||||||||
| Formula | C23H29F3O6 | ||||||||||||
| Molar Mass | 458.47 | ||||||||||||
| Appearance | Oil | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Zhang N, et al. The prostaglandin E2 receptor PTGER2 and prostaglandin F2α receptor PTGFR mediate oviductal glycoprotein 1 expression in bovine oviductal epithelial cells. J Reprod Dev. 2018;64(2):101-108. |
(+)-Fluprostenol
CAS: 54276-17-4 F: C23H29F3O6 W: 458.47
(+)-Fluprostenol is a potent agonist of PTGER2. (+)-Fluprostenol decreases the expression of Oviductal glycoprotein 1 (O
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.